Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 41.39.
Forward PE Ratio (41.39) = Close Price ($378.88) / Consensus Forward EPS ($9.15)
FORWARD PE RATIO
41.39
SECTOR MEDIAN · HEALTHCARE
19.91
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+107.83%
vs the sector median at left
Humana Inc.
Market Cap
$45.49B
Forward PE Ratio
41.39
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Humana Inc. (HUM) | $45.49B | 41.39 |
| Agilent Technologies, Inc. (A)vs › | $44.89B | 26.24 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $43.93B | 37.70 |
| IQVIA Holdings Inc. (IQV)vs › | $42.77B | 20.04 |
| Edwards Lifesciences Corporation (EW)vs › | $51.70B | 29.92 |
| Becton, Dickinson and Company (BDX)vs › | $52.90B | 15.15 |
| Cardinal Health, Inc. (CAH)vs › | $53.75B | 21.30 |
| DexCom, Inc. (DXCM)vs › | $34.85B | 34.61 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $33.80B | 15.19 |
| ResMed Inc. (RMD)vs › | $33.58B | 20.81 |
Trailing P/E
35.9
reported TTM EPS
Forward P/E
41.4
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $9.15 implies -13.4% EPS decline vs the reported trailing $10.56.
At today's $378.88 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $9.15 | $9.04 – $9.53 | 16 | 41.4x |
| 2027-12-31 | $16.72 | $11.40 – $19.87 | 16 | 22.7x |
| 2028-12-31 | $27.87 | $19.87 – $33.70 | 8 | 13.6x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
